MSL
ATRS

Mackay Shields LLC’s Antares Pharma, Inc. ATRS Stock Holding History

Mackay Shields LLC’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-256,100
Closed -$1.05M – 1454
2021
Q1 		$1.05M Sell
256,100
-169,200
-40% -$733K 0.01% 980
2020
Q4 		$1.7M Buy
425,300
+204,800
+93% +$663K 0.01% 910
2020
Q3 		$595K Buy
+220,500
New +$610K ﹤0.01% 1140

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Mackay Shields LLC's ATRS Position: Q2 2021 in Review

Mackay Shields LLC sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 256,100 shares — an estimated $1.05M sold.

Mackay Shields LLC first reported a position in ATRS in Q3 2020 and held it in 3 quarters. The position peaked at $1.7M in Q4 2020. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Mackay Shields LLC reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 256,100 Antares Pharma, Inc. shares in Q2 2021, an estimated $1.05M.
  • Mackay Shields LLC first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 3 quarters.
  • Mackay Shields LLC's Antares Pharma, Inc. position peaked at $1.7M in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.